Sands Capital Management Has Increased Makemytrip Limited Mauritius (MMYT) Stake By $11.45 Million; Heineken N.V. (HEINY) Had 3 Bulls

February 18, 2018 - By Evgen Dobrzhanskiy

Among 6 analysts covering Heineken (OTCMKTS:HEINY), 3 have Buy rating, 0 Sell and 3 Hold. Therefore 50% are positive. Heineken had 7 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Heineken N.V. (OTCMKTS:HEINY) earned “Neutral” rating by BNP Paribas on Thursday, February 16. The company was initiated on Monday, October 3 by Liberum Capital. Stifel Nicolaus initiated the shares of HEINY in report on Tuesday, November 22 with “Buy” rating. The stock of Heineken N.V. (OTCMKTS:HEINY) earned “Sector Perform” rating by RBC Capital Markets on Friday, August 7. The stock has “Outperform” rating by Bernstein on Friday, October 21. The firm has “Mkt Perform” rating given on Thursday, October 29 by Bernstein. The firm earned “Hold” rating on Tuesday, September 13 by Jefferies. See Heineken N.V. (OTCMKTS:HEINY) latest ratings:

Sands Capital Management Llc increased Makemytrip Limited Mauritius (MMYT) stake by 27.26% reported in 2017Q3 SEC filing. Sands Capital Management Llc acquired 408,750 shares as Makemytrip Limited Mauritius (MMYT)’s stock rose 2.51%. The Sands Capital Management Llc holds 1.91 million shares with $54.87M value, up from 1.50M last quarter. Makemytrip Limited Mauritius now has $2.86 billion valuation. The stock decreased 0.70% or $0.2 during the last trading session, reaching $28.3. About 484,115 shares traded or 56.47% up from the average. MakeMyTrip Limited (NASDAQ:MMYT) has risen 111.67% since February 18, 2017 and is uptrending. It has outperformed by 94.97% the S&P500.

The stock increased 0.60% or $0.32 during the last trading session, reaching $53.27. About 215,271 shares traded or 318.43% up from the average. Heineken N.V. (OTCMKTS:HEINY) has 0.00% since February 18, 2017 and is . It has underperformed by 16.70% the S&P500.

Heineken N.V. engages in brewing and selling beer. The company has market cap of $57.34 billion. The firm operates through Africa, Middle East & Eastern Europe; Americas; Asia Pacific; and Europe divisions. It has a 25.21 P/E ratio. It offers beer, cider, soft drinks, and other beverages.

Sands Capital Management Llc decreased Alexion Pharmaceuticals Inc (NASDAQ:ALXN) stake by 1.57 million shares to 4.78M valued at $670.02 million in 2017Q3. It also reduced Regeneron Pharmaceuticals (NASDAQ:REGN) stake by 154,049 shares and now owns 2.64 million shares. Schwab Charles Corp (NYSE:SCHW) was reduced too.